Antimicrobial Resistance Practice Questions

Q: The most common genetic element responsible for drug resistance in staphylococci is:

Plasmids. ***Plasmids*** - **Plasmids** are extrachromosomal DNA molecules that carry genes for antibiotic resistance, including **β-lactamase genes** and the **mecA gene** (responsible for methicillin resistance in MRSA). - Plasmids are the **primary genetic vehicles** for resistance in staphylococci and can be transferred between bacteria through various mechanisms (transduction, conjugation, transformation). - They enable rapid dissemination of **multi-drug resistance** patterns in staphylococcal populations. *Transduction* - **Transduction** is a horizontal gene transfer **mechanism** via bacteriophages, not a genetic element itself. - While transduction is actually the **most common transfer mechanism** in staphylococci (especially for plasmid and chromosomal DNA transfer), it is the **process** of transfer, not the genetic element carrying resistance genes. - The question asks about the genetic element, not the transfer mechanism. *Conjugation* - **Conjugation** is another horizontal gene transfer **mechanism** involving direct cell-to-cell contact, not a genetic element. - Conjugation is **relatively rare** in staphylococci compared to Gram-negative bacteria, though it can occur with certain plasmids. - Like transduction, this is a transfer process, not the genetic vehicle itself. *Translation* - **Translation** is the cellular process of protein synthesis from mRNA by ribosomes, completely unrelated to resistance gene acquisition. - While translation produces resistance proteins (like β-lactamase enzymes), it does not represent the genetic element that carries or transfers resistance genes.

Q: Which of the following is NOT a criterion for defining extensively drug-resistant tuberculosis (XDR-TB)?

Fluoroquinolone. ***Fluoroquinolone*** - Resistance to **fluoroquinolone alone** is NOT a criterion for XDR-TB because XDR-TB requires a **baseline of MDR-TB** (resistance to both rifampicin and isoniazid) plus additional resistances. - XDR-TB definition (WHO 2021): **MDR-TB** + resistance to **any fluoroquinolone** + resistance to **at least one Group A drug** (bedaquiline or linezolid). - Fluoroquinolone resistance in isolation does not meet any of these combined criteria. *Isoniazid + Rifampicin + Fluoroquinolone* - This represents **MDR-TB** (rifampicin + isoniazid resistance) plus **fluoroquinolone resistance**. - This is a partial criterion approaching XDR-TB but still requires additional resistance to at least one Group A drug (bedaquiline or linezolid) for complete XDR-TB classification. - However, this combination includes the essential MDR-TB base and fluoroquinolone component. *Isoniazid + Rifampicin + Ethambutol + Fluoroquinolone* - This includes **MDR-TB** (rifampicin + isoniazid), **fluoroquinolone resistance**, and ethambutol (first-line drug). - While ethambutol resistance alone doesn't define XDR-TB, this combination includes the critical MDR-TB and fluoroquinolone components required for XDR-TB classification. - Similar to above, would need Group A drug resistance for complete XDR-TB. *Isoniazid + Rifampicin + Kanamycin* - This represents **MDR-TB** plus resistance to **kanamycin** (a second-line injectable). - Under previous WHO definitions (pre-2021), injectable resistance was part of XDR-TB criteria. - This combination includes the MDR-TB base essential for any XDR-TB classification, though it lacks fluoroquinolone resistance.

Q: Multi-drug resistance tuberculosis implies resistance to at least -

Isoniazid and rifampicin. ***Isoniazid and rifampicin*** - **Multidrug-resistant TB (MDR-TB)** is specifically defined as resistance to at least both **isoniazid** and **rifampicin**, which are the two most potent first-line anti-TB drugs. - Absence of susceptibility to these two drugs makes treatment significantly more challenging and requires second-line agents. *Rifampicin and ethambutol* - While resistance to **rifampicin** is a criterion for MDR-TB, resistance to **ethambutol** alone (without isoniazid resistance) does not meet the definition of MDR-TB. - **Ethambutol** is a first-line drug but not one of the two core drugs whose resistance defines MDR-TB. *Isoniazid and ethambutol* - Resistance to **isoniazid** is a critical component of MDR-TB, but resistance to **ethambutol** alongside it does not fulfill the definition of MDR-TB unless **rifampicin** resistance is also present. - This combination would be considered **isoniazid-resistant TB**, but not multidrug-resistant. *Resistance to any two antitubercular drugs, excluding isoniazid and rifampicin.* - The definition of MDR-TB specifically requires resistance to **isoniazid** and **rifampicin**. - Resistance to any other two drugs, while problematic, does not qualify as MDR-TB if isoniazid and rifampicin are still effective.

Q: What is the mechanism of resistance in MRSA?

PBP2a alteration. ***PBP2a alteration*** - Methicillin-resistant Staphylococcus aureus (MRSA) acquires the **mecA gene**, which encodes for a modified penicillin-binding protein, **PBP2a**. - **PBP2a** has a low affinity for **beta-lactam antibiotics**, allowing the bacteria to synthesize its cell wall even in the presence of these drugs. *Efflux pump activation* - Efflux pumps are mechanisms used by bacteria to actively pump out various antibiotics from their cells, leading to resistance. - While efflux pumps contribute to resistance against other antibiotics, they are **not the primary mechanism** of methicillin resistance in MRSA. *Porins modification* - Porins are channels in the outer membrane of Gram-negative bacteria that allow the passage of hydrophilic molecules, including some antibiotics. - Modification of porins is a common resistance mechanism in **Gram-negative bacteria** but is not relevant to MRSA, which is Gram-positive. *Beta-lactamase production* - Beta-lactamases are enzymes that **hydrolyze the beta-lactam ring** of antibiotics like penicillin, rendering them inactive. - While many Staphylococcus aureus strains produce beta-lactamase (penicillinase) causing resistance to penicillins, MRSA's resistance to methicillin and other broader-spectrum beta-lactams is primarily due to **PBP2a alteration**, not just beta-lactamase production.

Q: Drug resistance is most seen with which STI?

Gonorrhoea. ***D. Gonorrhoea*** - *Neisseria gonorrhoeae* has a remarkable capacity to develop **antimicrobial resistance** through genetic mutations and horizontal gene transfer, leading to resistance to multiple classes of antibiotics, including cephalosporins. - The Centers for Disease Control and Prevention (CDC) monitors increasing resistance patterns and regularly updates treatment guidelines to combat this growing public health threat. *A. Chancroid* - Chancroid, caused by *Haemophilus ducreyi*, has shown some isolated instances of resistance to certain antibiotics like ciprofloxacin and erythromycin, but it is **not as widespread or severe** as observed with gonorrhoea. - Treatment typically involves single-dose azithromycin or ceftriaxone, which remain largely effective. *C. Syphilis* - Syphilis, caused by *Treponema pallidum*, has largely remained **susceptible to penicillin**, which has been the cornerstone of treatment for decades. - While there are rare reports of macrolide resistance, penicillin resistance has not emerged as a significant clinical problem. *B. Donovanosis* - Donovanosis (granuloma inguinale), caused by *Klebsiella granulomatis*, typically responds well to antibiotics like azithromycin, doxycycline, or trimethoprim-sulfamethoxazole. - **Antibiotic resistance is generally not a major concern** or a widespread issue in the treatment of donovanosis.

Q: Which STI has the highest rates of antibiotic resistance?

Gonorrhea. ***Gonorrhea*** - **Neisseria gonorrhoeae** has developed resistance to multiple classes of antibiotics, including **penicillins**, **tetracyclines**, **fluoroquinolones**, and increasingly to **cephalosporins**, making treatment challenging [1]. - This high rate of antibiotic resistance is a major public health concern, leading to treatment failures and the need for **dual therapy** with azithromycin and ceftriaxone to improve cure rates and slow resistance development [1]. *Chancroid* - Caused by **Haemophilus ducreyi**, which is generally susceptible to macrolides (e.g., azithromycin) and cephalosporins (e.g., ceftriaxone). - While resistance can occur, it is significantly **less prevalent** and widespread compared to gonorrhea. *Donovanosis* - Caused by **Klebsiella granulomatis**, which typically responds well to antibiotics like azithromycin, doxycycline, or trimethoprim-sulfamethoxazole. - Resistance is **rarely reported** and does not pose a major clinical challenge. *Syphilis* - Caused by **Treponema pallidum**, which remains highly susceptible to **penicillin G**, the drug of choice for all stages of syphilis [2]. - Although isolated cases of macrolide resistance have been noted, penicillin resistance is **extremely rare** and has not significantly impacted treatment recommendations [2].

Q: Which of the following antimicrobial resistance mechanisms are commonly observed in MRSA?

All of the options. ***All of the options*** - Methicillin-resistant *Staphylococcus aureus* (**MRSA**) has evolved multiple mechanisms to resist various antimicrobials, making it a significant clinical challenge. - These mechanisms collectively contribute to MRSA's resistance profile against several classes of antibiotics, not just beta-lactams. *Efflux pumps* - MRSA can possess **efflux pumps** that actively transport antibiotics out of the bacterial cell, thereby reducing their intracellular concentration and effectiveness. - This mechanism is particularly relevant for resistance to **tetracyclines** and **macrolides**. *Alteration of drug targets* - The defining mechanism of methicillin resistance in MRSA is the production of an altered **penicillin-binding protein (PBP2a)**, encoded by the *mecA* gene. - This **altered target** has a low affinity for beta-lactam antibiotics, rendering them ineffective in inhibiting cell wall synthesis. *Beta-lactamase production* - While target alteration (PBP2a) is the primary mechanism for methicillin resistance, many MRSA strains also produce various **beta-lactamase enzymes**. - These enzymes **hydrolyze** the beta-lactam ring of penicillin and some cephalosporins, contributing to their original penicillin resistance before the development of true methicillin resistance.

Q: How does penicillin resistance most commonly develop in bacteria?

Through the production of beta-lactamases. ***Through the production of beta-lactamases*** - The most common mechanism of penicillin resistance involves the production of **beta-lactamases** (also known as penicillinases). These enzymes hydrolyze the **beta-lactam ring** structure common to penicillins, rendering the antibiotic inactive. - This enzymatic degradation prevents the antibiotic from binding to **penicillin-binding proteins** within the bacterial cell wall, which are essential for cell wall synthesis. *Through the loss of penicillin-binding proteins* - While **alterations** in penicillin-binding proteins (PBPs) can contribute to resistance, outright **loss** of these essential proteins is generally not a viable resistance mechanism as they are crucial for bacterial survival. - Bacteria often develop resistance by **mutating the structure** of their PBPs so that penicillin can no longer bind effectively, rather than completely losing them. *By decreasing permeability to the antibiotic* - Decreased permeability can contribute to resistance by **reducing the intracellular concentration** of the antibiotic, but it is less common for penicillin resistance compared to beta-lactamase production. - This mechanism is more frequently observed in **Gram-negative bacteria** due to their outer membrane, which can be modified to restrict antibiotic entry via porins. *By altering the ribosomal binding sites* - Altering ribosomal binding sites is a mechanism of resistance specifically against antibiotics that target **bacterial ribosomes** (e.g., macrolides, tetracyclines, aminoglycosides). - Penicillins, however, target **cell wall synthesis** by inhibiting penicillin-binding proteins, not ribosomal function.

Q: Multidrug-resistant (MDR) tuberculosis shows resistance to which of the following drugs?

Isoniazid and rifampicin only. ***Isoniazid and rifampicin only*** - **Multidrug-resistant (MDR) tuberculosis** is specifically defined by resistance to both **isoniazid** and **rifampicin**. - These two drugs are considered the most effective first-line anti-TB medications, making resistance to both a significant treatment challenge. *Isoniazid, rifampicin, and fluoroquinolone* - Resistance to **isoniazid**, **rifampicin**, and *any* fluoroquinolone defines **pre-extensively drug-resistant (pre-XDR) TB**, not MDR-TB. - Adding resistance to a fluoroquinolone indicates a more severe and harder-to-treat form of tuberculosis. *Fluoroquinolone* - Resistance to **fluoroquinolone** alone does not define MDR-TB; it is only one component of resistance that, when combined with resistance to isoniazid and rifampicin, signifies pre-XDR or XDR-TB. - While fluoroquinolones are important second-line drugs, their resistance in isolation does not meet the criteria for MDR-TB. *Isoniazid, rifampicin, and kanamycin* - Resistance to **isoniazid**, **rifampicin**, and *any* second-line injectable agent (like **kanamycin**, capreomycin, or amikacin) defines **extensively drug-resistant (XDR) TB**, not MDR-TB. - XDR-TB represents an even more complex and difficult form of the disease to treat, requiring highly specialized regimens.

Q: Which of the following is an example of the transfer of drug resistance by conjugation?

E coli to streptomycin. **E coli to streptomycin** - The transfer of **streptomycin resistance** in *E. coli* is a classic example of **conjugation**, mediated by **transferable R-plasmids**. - **Conjugation** involves direct cell-to-cell contact and the transfer of genetic material via a **pilus**, allowing for efficient spread of resistance genes. *Staphylococci to rifampicin* - **Rifampicin resistance** in *Staphylococci* (e.g., MRSA) primarily results from **chromosomal mutations** in the *rpoB* gene, which alters the drug's binding site. - This type of resistance usually arises through **spontaneous mutation and selection**, rather than active transfer via conjugation. *Pneumococcus to penicillin G* - **Penicillin resistance** in *Pneumococcus* (e.g., **PEN-R *S. pneumoniae***) is often due to alterations in **penicillin-binding proteins (PBPs)**, acquired through **transformation**. - Transformation involves the uptake of **naked DNA** from the environment, not direct cell-to-cell contact as in conjugation. *M tuberculosis to antitubercular drugs* - **Drug resistance** in *Mycobacterium tuberculosis* to antitubercular drugs (such as isoniazid and rifampicin) is predominantly mediated by **chromosomal mutations**. - These mutations occur within genes encoding drug targets or drug-activating enzymes, leading to altered drug sensitivity.

Question 1

The most common genetic element responsible for drug resistance in staphylococci is:

Accepted Answer

Plasmids

Answer

Transduction

Answer

Conjugation

Answer

Translation

Question 2

Which of the following is NOT a criterion for defining extensively drug-resistant tuberculosis (XDR-TB)?

Accepted Answer

Fluoroquinolone

Answer

Isoniazid + Rifampicin + Fluoroquinolone

Answer

Isoniazid + Rifampicin + Ethambutol + Fluoroquinolone

Answer

Isoniazid + Rifampicin + Kanamycin

Question 3

Multi-drug resistance tuberculosis implies resistance to at least -

Accepted Answer

Isoniazid and rifampicin

Answer

Rifampicin and ethambutol

Answer

Isoniazid and ethambutol

Answer

Resistance to any two antitubercular drugs, excluding isoniazid and rifampicin.

Question 4

What is the mechanism of resistance in MRSA?

Accepted Answer

PBP2a alteration

Answer

Efflux pump activation

Answer

Porins modification

Answer

Beta-lactamase production

Question 5

Drug resistance is most seen with which STI?

Accepted Answer

Gonorrhoea

Answer

Chancroid

Answer

Syphilis

Answer

Donovanosis

Question 6

Which STI has the highest rates of antibiotic resistance?

Accepted Answer

Gonorrhea

Answer

Chancroid

Answer

Donovanosis

Answer

Syphilis

Question 7

Which of the following antimicrobial resistance mechanisms are commonly observed in MRSA?

Accepted Answer

All of the options

Answer

Efflux pumps

Answer

Alteration of drug targets

Answer

Beta-lactamase production

Question 8

How does penicillin resistance most commonly develop in bacteria?

Accepted Answer

Through the production of beta-lactamases

Answer

Through the loss of penicillin-binding proteins

Answer

By decreasing permeability to the antibiotic

Answer

By altering the ribosomal binding sites

Question 9

Multidrug-resistant (MDR) tuberculosis shows resistance to which of the following drugs?

Accepted Answer

Isoniazid and rifampicin only

Answer

Isoniazid, rifampicin, and fluoroquinolone

Answer

Fluoroquinolone

Answer

Isoniazid, rifampicin, and kanamycin

Question 10

Which of the following is an example of the transfer of drug resistance by conjugation?

Accepted Answer

E coli to streptomycin

Answer

Staphylococci to rifampicin

Answer

Pneumococcus to penicillin G

Answer

M tuberculosis to antitubercular drugs

Antimicrobial Resistance — MCQs

Antimicrobial Resistance — MCQs

On this page

Practice by Chapter

Want unlimited practice?